4 recruiting, 1 not yet recruiting, 1 unknown. 4 Phase 3, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
| Phase 4 | 1 | Unknown 1 |
Follow tebufenozide: new trials by email Literature Review of tebufenozide trials Research Report on tebufenozide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome) Chang Ji'an capsule, Chang Ji'an capsule mimic - IBS, Diarrhea Predominant | Phase 3 | Not yet recruiting | Beijing Hospital of Traditional Chinese Medicine | 636 | 2026-05-31 | 2026-05-28 |
| Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder Crisugabalin 20mg bid, Venlafaxine-XR 75mg bid, Crisugabalin capsules mimic 0mg/capsule bid - Generalized Anxiety Disorder | Phase 2 | Recruiting | Anhui Medical University | 216 | 2025-10-10 | 2026-01-09 |
| Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma Xinlikang capsules, mimic capsules - Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2 / Phase 3 | Recruiting | Sun Yat-sen University | 80 | 2025-09-11 | 2025-11-26 |
| Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD Buagafuran capsules, 15mg/ capsule, Buagafuran capsules mimic, 0mg/ capsule - Generalized Anxiety Disorder | Phase 3 | Recruiting | Beijing Union Pharmaceutical Factory Ltd | 504 | 2023-07-25 | 2024-02-06 |
| Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD Buagafuran capsules, 15mg/ capsule, Buspirone tablets, 5mg/ tablet, Buagafuran capsules mimic, 0mg/ capsule - Generalized Anxiety Disorder | Phase 3 | Recruiting | Beijing Union Pharmaceutical Factory Ltd | 410 | 2023-07-24 | 2024-02-06 |
| The Effects of Allicor on Patients After Revascularization Treatment During a Year Allicor, Placebo - Atherosclerosis, Peripheral Arterial Disease | Phase 4 | Unknown | Institute for Atherosclerosis Research, Russia | 300 | 2023-04-20 | 2023-04-19 |
Generalized Anxiety Disorder (3) · Atherosclerosis (1) · Ichthyosis Bullosa of Siemens (1) · Inflammation (1) · Lymphoma, Large B-Cell, Diffuse (1) · Peripheral Arterial Disease (1)
Beijing Union Pharmaceutical Factory Ltd (2) · Anhui Medical University (1) · Beijing Hospital of Traditional Chinese Medicine (1) · Institute for Atherosclerosis Research, Russia (1) · Sun Yat-sen University (1)
China (5) · Russia (1)